Evidence map›Paper›PMID 30643882›Full record

ArticleMicrobiology resource announcements2019

Draft Genome Sequence of

Ghazaleh Jahanshah, Henrike Miess, Tobias Busche, Christian Rückert, Jörn Kalinowski, Hassan Rokni-Zadeh, Harald Gross

Abstract read
In one paragraph

Article in Microbiology resource announcements, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghazaleh JahanshahDepartment of Pharmaceutical Biology, Institute of Pharmaceutical Sciences, University of Tübingen, Tübingen, Germany.
Henrike MiessDepartment of Pharmaceutical Biology, Institute of Pharmaceutical Sciences, University of Tübingen, Tübingen, Germany.
Tobias BuscheTechnology Platform Genomics, CeBiTec, Bielefeld University, Bielefeld, Germany.
Christian RückertTechnology Platform Genomics, CeBiTec, Bielefeld University, Bielefeld, Germany.
Jörn KalinowskiTechnology Platform Genomics, CeBiTec, Bielefeld University, Bielefeld, Germany.
Hassan Rokni-ZadehDepartment of Medical Biotechnology and Nanotechnology, Zanjan University of Medical Sciences, Zanjan, Iran.
Harald GrossDepartment of Pharmaceutical Biology, Institute of Pharmaceutical Sciences, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-0731-821X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strain MW13 exhibited broad-spectrum antibacterial activity toward Gram-positive and Gram-negative pathogens. The 7.1-Mb draft genome gives insight into the complete secondary metabolite production capacity and reveals genes putatively responsible for its antibacterial activity, as well as genes which contribute to plant growth promotion.

Identifiers

PMID30643882
PMCPMC6328655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.